Successful therapeutic vaccination with integrase defective lentiviral vector expressing nononcogenic human papillomavirus E7 protein.
about
Recent Advances in Lentiviral Vaccines for HIV-1 InfectionRecent Progress in Therapeutic Treatments and Screening Strategies for the Prevention and Treatment of HPV-Associated Head and Neck CancerHPV in oropharyngeal cancer: the basics to know in clinical practicePerspectives for therapeutic HPV vaccine developmentMucosal immunization with integrase-defective lentiviral vectors protects against influenza virus challenge in miceOptimization of mucosal responses after intramuscular immunization with integrase defective lentiviral vectorA nonintegrative lentiviral vector-based vaccine provides long-term sterile protection against malariaA Lentiviral Vector Expressing Japanese Encephalitis Virus-like Particles Elicits Broad Neutralizing Antibody Response in Pigs.Therapeutic Vaccine Strategies against Human Papillomavirus.Simian immunodeficiency virus-Vpx for improving integrase defective lentiviral vector-based vaccines.Chimeric HBcAg virus-like particles presenting a HPV 16 E7 epitope significantly suppressed tumor progression through preventive or therapeutic immunization in a TC-1-grafted mouse model.Immunization with an SIV-based IDLV Expressing HIV-1 Env 1086 Clade C Elicits Durable Humoral and Cellular Responses in Rhesus Macaques.Nanoparticle-delivered transforming growth factor-β siRNA enhances vaccination against advanced melanoma by modifying tumor microenvironment.Recent progress in vaccination against human papillomavirus-mediated cervical cancer.Current state in the development of candidate therapeutic HPV vaccinesIntegrase Defective Lentiviral Vector as a Vaccine Platform for Delivering Influenza Antigens.Design and Potential of Non-Integrating Lentiviral Vectors.
P2860
Q26742169-184F9C18-34F8-421A-8773-419C92DD6248Q26782255-D65DB3AE-AC8D-4615-8BF2-40DAC300B51EQ26853669-D3F834CF-78D0-43B2-A520-462D41258CFEQ28069272-775335F2-F85A-4201-8BAB-1FCE8F63B637Q33604567-CDE63FBD-48C4-4144-AC43-74E84D4EF9C6Q34166320-56F2EEBD-C5D5-4061-95DF-CEAAEF26D79BQ34469817-94C02E80-DCF7-4C65-9066-1B1C7B78FFFBQ35799379-9A398E13-3386-4B44-8C28-D7AA12CC42C0Q35826752-15B35F07-8D40-4B7F-957E-27C661ACB063Q36308990-3F7EDD4E-63E1-4E32-BD92-F68DB7A6F2A7Q36967911-80A69629-95C7-4637-8591-F26BF541FF98Q37499531-A56B77E4-14E7-4AB2-A5F5-CC240C817BCDQ37731681-31B668EC-9E9F-4142-AFB2-3FD6451EC441Q38370782-2D9C7CDF-4787-421B-864A-516576C078A3Q38743922-AE28C0CA-46A9-467A-BF1B-B875C4B95149Q49829189-5BAAB159-6684-48A0-AF03-91F8C5463D35Q51851755-E4558086-F1F5-4302-9310-760BFDC5B4CF
P2860
Successful therapeutic vaccination with integrase defective lentiviral vector expressing nononcogenic human papillomavirus E7 protein.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Successful therapeutic vaccina ...... man papillomavirus E7 protein.
@en
Successful therapeutic vaccina ...... man papillomavirus E7 protein.
@nl
type
label
Successful therapeutic vaccina ...... man papillomavirus E7 protein.
@en
Successful therapeutic vaccina ...... man papillomavirus E7 protein.
@nl
prefLabel
Successful therapeutic vaccina ...... man papillomavirus E7 protein.
@en
Successful therapeutic vaccina ...... man papillomavirus E7 protein.
@nl
P2093
P2860
P50
P356
P1476
Successful therapeutic vaccina ...... uman papillomavirus E7 protein
@en
P2093
Andrea Giovannelli
Armando Cesolini
Colomba Giorgi
Felicia Grasso
Pasqualina Leone
Stefania Mochi
P2860
P304
P356
10.1002/IJC.27676
P577
2012-06-28T00:00:00Z